Cargando…
Association of plasminogen activator inhibitor-1 and fibroblastic growth factor 21 in 3 groups of type 2 diabetes: Without overweight/obesity, free of insulin resistance, and without hepatosteatosis
The physiological effects of fibroblast growth factor 21 (FGF21), leading to beneficial metabolic outcomes, have been extensively revealed in recent decades. Significantly elevated serum levels of FGF21 in obesity and type 2 diabetes mellitus (T2DM) are referred to as FGF21 resistance. However, Asia...
Autores principales: | Takebe, Noriko, Hasegawa, Yutaka, Matsushita, Yuriko, Chiba, Hiraku, Onodera, Ken, Kinno, Hirofumi, Oda, Tomoyasu, Nagasawa, Kan, Segawa, Toshie, Takahashi, Yoshihiko, Okada, Kenta, Ishigaki, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476825/ https://www.ncbi.nlm.nih.gov/pubmed/37657012 http://dx.doi.org/10.1097/MD.0000000000034797 |
Ejemplares similares
-
Adiponectin Paradox More Evident in Non-Obese Than in Obese Patients with Diabetic Microvascular Complications
por: Satoh, Ken, et al.
Publicado: (2023) -
Serum C‐X‐C motif chemokine ligand 14 levels are associated with serum C‐peptide and fatty liver index in type 2 diabetes mellitus patients
por: Matsushita, Yuriko, et al.
Publicado: (2020) -
The Effects of Imeglimin on the Daily Glycemic Profile Evaluated by Intermittently Scanned Continuous Glucose Monitoring: Retrospective, Single-Center, Observational Study
por: Oda, Tomoyasu, et al.
Publicado: (2022) -
Cardiovascular Autonomic Dysfunction Predicts Diabetic Foot Ulcers in Patients With Type 2 Diabetes Without Diabetic Polyneuropathy
por: Yun, Jae-Seung, et al.
Publicado: (2016) -
Agenesis of the dorsal pancreas: a rare cause of insulin-dependent diabetes without abdominal pain: Case report
por: Liang, Kaiyong, et al.
Publicado: (2018)